Overview: an iPS cell stock at CiRA
Open Access
- 2 September 2019
- journal article
- review article
- Published by Springer Nature in Inflammation and Regeneration
- Vol. 39 (1) , 1-5
Abstract
Induced pluripotent stem cells (iPSCs) can be produced from various somatic cells and have the ability to differentiate into various cells and tissues of the body. Regenerative medicine using iPSCs is expected to manage diseases lacking effective treatments at present. We are establishing a safe and effective iPSC stock that can be used for regenerative medicine. Our iPSC stock is recruited from healthy, consenting HLA-type homozygous donors and is made with peripheral blood-derived mononuclear cells or umbilical cord blood. We hope to minimize the influence of immune rejection by preparing HLA homozygous iPSCs. Our stock is made at the Cell Processing Center (CPC), Center for iPS Cell Research and Application (CiRA). We are preparing iPS cells that maximize matching of the Japanese population at the major HLA loci. This iPSC stock is intended to be offered not only to Japanese centers but also overseas medical institutions and companies. In August 2015, we began offering the iPSC stock for regenerative medicine and now offer 21 clones made from 5 donors.Keywords
Funding Information
- Japan Agency for Medical Research and Development (18bm0104001h0006)
This publication has 26 references indexed in Scilit:
- NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCsStem Cell Reports, 2017
- MHC matching improves engraftment of iPSC-derived neurons in non-human primatesNature Communications, 2017
- Autologous Induced Stem-Cell–Derived Retinal Cells for Macular DegenerationNew England Journal of Medicine, 2017
- Immunogenicity of Induced Pluripotent Stem CellsCirculation Research, 2011
- Immunogenicity of induced pluripotent stem cellsNature, 2011
- A more efficient method to generate integration-free human iPS cellsNature Methods, 2011
- Promotion of direct reprogramming by transformation-deficient MycProceedings of the National Academy of Sciences, 2010
- Generation of mouse-induced pluripotent stem cells with plasmid vectorsNature Protocols, 2010
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006